The United States Food and Drug Administration has approved the Harmony Transcatheter Pulmonary Valve System, the first non-surgical heart valve to treat pediatric and adult patients with congenital heart defects, which affect approximately 40,000 babies each year.1 The device is intended to improve blood flow to the lungs without requiringRead More →

When echocardiography results are unclear, fetal cardiovascular MRI (CMR) can provide valuable information about congenital heart defects, leading to changes in treatment or management decisions in more than 80% of cases, reports a new study. Not only could this imaging information be used to augment treatment for infants, a teamRead More →

Scientists examining the beating heart have solved a fundamental decades-old mystery about how the heart works. This revelation could herald the development of new treatments for heart disease, the leading cause of death worldwide. Researchers from Eastern Virginia Medical School, Florida State University and the University of Virginia have observedRead More →

Previous research on risk factors for obstructive heart defects (OHD) has focused on maternal and infant genetic variants, prenatal environmental exposures, and their potential interacting effects. Less is known about the role of paternal genetic variants or environmental exposures and the risk of OHD. We examined the effects of originalRead More →